UBS crosses 3 percent in Azelis. Azelis stock sits 14.50 percent below EUR 15.00 target

Published on 10/20/2026 at 09:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UBS's position briefly included 7,368,510 voting rights and instruments. Azelis stock costs EUR 13.10 on October 20, 2026, versus a EUR 15.00 target.

Institutional position and earnings dates

UBS held 3.02 percent of Azelis voting rights and equivalent instruments on October 8, 2026.
Jefferies forecast third-quarter EBITA of EUR 108.0 million on October 12, 2026.
Azelis stock traded at EUR 13.10 at 9:41 a.m. CEST at Lang & Schwarz on October 20, 2026.
Azelis expects its sales and revenue release on October 21, 2026.

Azelis, BE0974400328, Illustration mit AI erstellt.

Azelis (BE0974400328) stock was trading at EUR 13.10 at Lang & Schwarz on October 20, 2026 at 9:41 a.m. CEST. In a Business Wire release dated October 13, 2026, Azelis reported that UBS had crossed the 3 percent threshold on October 8, reaching 3.02 percent through voting rights and equivalent instruments. Jefferies analyst David Kerstens kept a EUR 15.00 price target on October 12, 2026, according to The Asset.

UBS position reached 3.02 percent

The disclosure gives investors a precise picture of the institutional move. UBS held 1,090,312 voting shares, equal to 0.45 percent of Azelis's issued shares, and 6,278,198 equivalent financial instruments, equal to 2.57 percent, for a combined 3.02 percent on October 8, 2026.

What could support the EUR 15.00 target?

Jefferies expected Azelis's third-quarter EBITA to recover 10 percent to EUR 108.0 million, below consensus of EUR 113.4 million, in the report dated October 12, 2026. For fiscal year 2026, the analyst projected EBITA of EUR 424.4 million against consensus of EUR 436.0 million. The figures make earnings execution the central test for the valuation.

Three dated steps before results

On October 8, 2026, UBS reached 3.02 percent through shares and equivalent instruments. On October 12, 2026, Jefferies projected third-quarter EBITA of EUR 108.0 million and retained its EUR 15.00 target. On October 13, 2026, Azelis disclosed the UBS notifications covering the October 8 and October 9 threshold transactions.

Reporting dates are next

Azelis is scheduled for a sales and revenue release on October 21, 2026, as listed by MarketScreener. The Asset reported that Azelis was due to publish figures on October 22, 2026, giving the upcoming results window two closely spaced dates in current market coverage.

Stock price and investor context

The EUR 15.00 Jefferies target stands EUR 1.90 above the Lang & Schwarz price, an implied 14.50 percent above the price. That gap places the upcoming sales and revenue update alongside the EBITA recovery estimate as the next concrete valuation checkpoints.

The further course of trading is shown by the continuously updated real-time quote of Azelis stock.